Pfizer

An increasingly mature multinational sector, our reliance on a few big companies and changes in global tax rules will all affect future tax revenues

Pharmaceutical-related products accounted for almost two-thirds of Irish goods exports last year

Pharmaceutical giant suffers a post-Covid-19 hangover as demand for pandemic vaccines and medicines falls sharply

US drugmaker is trying to chart its future without blockbuster Covid-19 products

After three months of weak returns, ministers breathed a sigh of relief thanks to a bumper return for November

The old story of the Republic’s two-tier economy is alive and well

Albert Bourla, chief executive of US pharma giant, accepts IDA Ireland’s Special Recognition Award on behalf of the company

Pharma group cutting staff at Newbridge plant but also adding 230 staff to Grange Castle and Ringaskiddy sites

Drugmaker makes first quarterly loss in decades as Irish staff wait for news on jobs

German pharmaceutical company shot to fame as first company to produce a next-generation mRNA vaccine to treat Covid-19

US medicines giant says it needs to find €3.3bn in annual cost savings by the end of next year

British medicines group and US rival Pfizer have both committed to selling down stakes over time to fund core pharma operations

Hospitalisations from Covid-19 have crept up in recent weeks, although the rise is lower than the same time last year

Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades

IDA believes State’s still modest tax rate, political stability and skill base will attract pharma and medical companies

Euro zone statistics have been seriously distorted by US tech and pharma groups that found a home in Dublin, writes FT columnist Martin Arnold

Pfizer’s second-quarter results confirm sharp fall in demand for vaccines and other Covid medicines produced in Ireland

Company preparing for many of its top-selling drugs to be soon facing competition from cheaper generics

Cork native talks FDI, employee ownership and work-life balance ahead of his retirement

Project delivery specialist reported operating profits of €44m for 2022

Rise in receipts to record €26bn linked to jump in contract manufacturing by several Irish-based firms

Reliance on a handful of firms has inverted Ireland’s traditional relationship between government and industry. Sinn Féin in power would have to maintain that dynamic

Irish Fiscal Advisory Council report suggests business tax base even more concentrated around small number of firms than previously thought

Milestone Solutions provides IT and automation services to large multinational manufacturing companie

Leonard Schleifer describes largest pharma sector M&A of 2022 as ‘worst thing for our industry’

One of the biggest threats to public health today is antibiotic resistant infections. What can be done to remedy such risks?

Athenry’s 1,000-job bonanza comes against ongoing concern about the carrying capacity of the Irish economy

US medical device company says facility will create 1,000 jobs in region

Group says it remains on track to achieve its 7%-9% revenue growth from other products this year

European health officials have advocated portfolio diversity to help fight different variants

More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out

As the end of the pandemic brings Pfizer to a year of transition, its country manager for Ireland says the group’s drug pipeline is the strongest it’s ever been

Multinational chief executives stress the importance of creating a more level playing field if China wants to attract more foreign investment

Trade union Unite says it is considering appeal of High Court decision

EU ethics controversies ‘play into the hands of Eurosceptics and anti-vaxxers’, says European Ombudsman

US pharma group plans to pay $229 in cash per share as it aims to ‘advance the battle against cancer’

Novavax had a terrible week while Pfizer and Moderna are well off their pandemic highs

Questions remain about hospitalisation and side effects but drugmaker stays step ahead of British group GSK which faces similar panel

Manufacturing woes meant it lost out in race to market with its Covid vaccine

Pharma group is launching 19 drugs over the next 18 months to counteract a sharp fall in sales from pandemic highs